Results

Total Results: 1,187 records

Showing results for "weeks".

201. Total Worker Health® (TWH) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
     April 01, 2016 - The draft was posted on the AHRQ Web site for 4 weeks to elicit public comment. … that more workers at intervention worksites than at control worksites reported 7-day abstinence at 22 weeks … Low for benefit Sedentary office workers46,49 Integrated intervention vs. any comparator 16–52 weeks … , increasing fruit and vegetable intake over 26 to 104 weeks, and reducing sedentary work activity … over 16 to 52 weeks.

202. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
     May 01, 2013 - the diagnostic criteria listed in Table 1, with a secondary criterion of onset of symptoms within 4 weeks … months after delivery.2 Other diagnostic standards allow the definition of onset to extend beyond 4 weeks … first contact with a primary care provider, at her booking visit, and postnatally (usually at 4 to 6 weeks … gestation and 6 weeks postpartum, versus screening with a test of sensitivity A% and specificity B% … Risk factors for postpartum depression: a retrospective investigation at 4-weeks postnatal and a review

203. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
     March 08, 2012 - Efficacy and safety beyond 3 weeks in patients with SAR have not been established.32 5. … How does effectiveness vary with long-term (months) or short-term (weeks) use? b. … How do adverse effects vary with long-term (months) and short-term (weeks) use? b. … How do effectiveness and adverse effects vary with long-term (months) or short-term (weeks) use? … How do effectiveness and adverse effects vary with long-term (months) or short-term (weeks) use?

204. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - At 26 weeks after balloon removal, 45.9% of the balloon group achieved excess weight loss of 25% or … In late November 2015, about 26 weeks after product launch, about 2,300 Saxenda prescriptions per week … At 26 weeks (balloon removal), 71.8% of the balloon group achieved 25% or more EWL, compared with 31.9% … At 52 weeks (26 weeks after balloon removal), 45.9% of the balloon group achieved 25% or more EWL, … The ReShape group was reported to have achieved significantly greater %EWL at 24 weeks (25.1% ITT

205. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - and responders was less than one would like with a treatment that requires daily intervention for 3 weeks … Sackeim and colleagues (2001) in a group of 83 unipolar depressed patients followed for up to 24 weeks … Memory Interview-Short Form, AMI-SF) memory were obtained prior to first treatment, and at 4 and 6 weeks … ; P = 0.0038 at 6 weeks) and delayed recall (P = 0.0463 at 4 weeks; P = 0.0012 at 6 weeks). … with current minimum duration of treatment as articulated in FDA-cleared product labeling (i.e., 4 weeks

206. Disposition of Comments_Technical Brief No. 45: Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-disposition-comments.pdf
     January 01, 2022 - The Introduction note that the duration of long COVID ranges from weeks to years, which is consistent … defined long COVID as symptoms persisting for 12 weeks or more." … Most definitions refer to presence of symptoms longer than a specified period of weeks/months after … for at least 4 weeks (since symptoms can be new, recurring OR persisting). … and “post- COVID-19 syndrome” as presence of symptoms for >12 weeks."

207. American Medical Association (AMA) App Challenge and AMA Idealab (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/eaagleston.pdf
     May 29, 2025 - Members voted for roughly around six weeks. … Our voting was open for six weeks.

208. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - They reported that after 24 weeks, the mean excess weight loss in the Duo balloon group was 31.8%±21.3% … Weight loss in pounds or kilograms was not reported.6 The authors reported that at 48 weeks, which … was 24 weeks after device removal, patients treated with ReShape Duo had maintained 64% of their weight … After 56 weeks of treatment, patients taking the drug had statistically significant improvements in … After 56 weeks, patients discontinued treatment and were observed for an additional 12 weeks.55 A company

209. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
     January 01, 2020 - The duration of the vibration intervention ranged from 8-72 weeks, as did the length of followup for … Intervention Length of Followup 12-40 Hz 0.7-5 mm 0.1-10 g 15 s-30 min 1-7 days per week 8-72 weeks … 8-72 weeks Outcomes The distribution of outcomes assessed in the 12 whole-body vibration studies … who had a diagnosis of any underlying disease or chronic illness; Females who had been ill for >2 weeks … 3 minutes, Last 6 weeks 6 minutes Yes - 1 minute vibration, 1 minute rest No No Yes No

210. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - GI medication, weight-reducing medication, statins, or glucocorticoids within 12 weeks before the screening … disease, use of laxatives or other confounding medications, iron or calcium supplements 5 wk NA 35/35 d Weeks … cancer, medications that affect metabolism, glycemia, appetite or bowel habits 6 wk NA NR 3 days in weeks … trial; consuming vitamin, fish oil, evening primrose oil or mineral supplements; 8 wk NA NR/unclear Weeks … parallel < 2003 Industry funding of study NR Community 4–12 mo, former term newborns >=37 and <=42 weeks

211. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - GI medication, weight-reducing medication, statins, or glucocorticoids within 12 weeks before the screening … disease, use of laxatives or other confounding medications, iron or calcium supplements 5 wk NA 35/35 d Weeks … cancer, medications that affect metabolism, glycemia, appetite or bowel habits 6 wk NA NR 3 days in weeks … trial; consuming vitamin, fish oil, evening primrose oil or mineral supplements; 8 wk NA NR/unclear Weeks … parallel < 2003 Industry funding of study NR Community 4–12 mo, former term newborns >=37 and <=42 weeks

212. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
     December 31, 2022 - recipients were matched with 35 immunocompetent controls and were followed for a median of 6.3 and 6.9 weeks … prospective cohort studies27-30 comparing characteristics of patients who did not seroconvert after 6 weeks … greater than 12 months among unvaccinated adults, (2) predictors of non-seroconversion at least six weeks … (5.6–9.35)~ 35/35 (100%) — 6.9 (5.35–7.55)~ IgG anti-S 34/35 (97%) — 6.3 weeks (5.6–9.35)~ 35/35 ( … 100%) — 6.9 (5.35–7.55)~ Neutralizing Ab 29/35 (83%) — 6.3 weeks (5.6–9.35)~ 29/29 (100%) — 6.9 (

213. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
     December 05, 2013 - Before implantation, patients are required to have tried at least 6 weeks of conservative treatment … the same day (for preparations that undergo only centrifugation with no additives) or up to a few weeks … score at all timepoints and significantly greater 3 improvement in VAS neck pain score at 6 weeks … Before device implantation, patients must have tried at least 6 weeks of conservative treatment or … Followup evaluation was performed at 3 weeks, 3 months, and 6 months by a blinded, independent observer

214. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
     January 01, 2017 - Timing: • Minimum duration of followup: 12 weeks. … We included trials with study populations of mostly outpatients and duration of at least 12 weeks, … In addition, the draft report was posted on the AHRQ Web site for 4 weeks to elicit public comment. … months • No difference between paliperidone palmitate LAI (monthly) and risperidone LAI (every 2 weeks … Symptoms: Improvements in Total Scale Scores • CBT: Benefit over usual care during treatment (8 weeks

215. Effect-Dietary-Digestible (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible.pdf
     January 01, 2021 - and obesity • Type 1 Diabetes Timing • Type 2 diabetes • Minimum intervention length of 12 weeks … Effect on growth, size, and body composition o Minimum intervention length of 12 weeks • Any … intervention length <12 weeks Settings • All except hospital and acute care • Hospital and acute care

216. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - n = 1,099) were given boceprevir in combination with IFN-RBV in one of two treatment regimens (48 weeks … of boceprevir plus IFN-RBV or 24 weeks of boceprevir plus IFN-RBV for 24 or 48 weeks) or 48 weeks … In the control arm, 44% of patients achieved an SVR after 48 weeks of treatment with IFN-RBV. 10 … Samples were taken once weekly for 10 weeks; after 5 weeks, the copper-containing and noncopper items … This is a direct result of current TB testing methods, which require weeks to deliver a definitive

217. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - After 24 weeks of treatment, 54% of patients treated with teduglutide were able to reduce the number … Treatment response (defined as least 20% reduction in PN or intravenous volume from baseline to weeks … week reduction in PN support versus a 0.9 liter per week reduction for patients given placebo at 24 weeks … uncontrolled extension of the second trial, patients (n=65) received teduglutide for up to an additional 28 weeks … used to increase nutrient absorption; however, somatropin has not been evaluated for longer than 4 weeks

218. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - It did not meet our inclusion criteria because it was <12 weeks. … The newer quetiapine study was <12 weeks in duration. … Although most alcohol clinical trials are at least 12weeks, there are some at 8 weeks. … I am not sure why the exclusion is less than 12 weeks. … Both were less than 12 weeks in duration. These are in the appendix of excluded studies.

219. Disposition of Comments for CER 202 Effectiveness and Safety of Bronchial Thermoplasty in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
     December 14, 2017 - mild exacerbations, but also noted our concern that measuring exacerbations rates only during the 2 weeks … However, we have clarified that the post-bronchodilator result at 22 and 52 weeks was not significant … difference was not significant at 52 weeks” while “In the other study, patients treated with BT and … from baseline; the between-group difference was not significant at 52 weeks. … The risk of adverse events is higher early in treatment while benefit is typically observed weeks

220. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes